Merck & Co., Inc. (BCBA:MRK)

Argentina flag Argentina · Delayed Price · Currency is ARS
20,175
+100 (0.50%)
At close: Jul 4, 2025, 5:00 PM BRT
-37.04%
Market Cap 256.83T
Revenue (ttm) 68.59T
Net Income (ttm) 18.71T
Shares Out n/a
EPS (ttm) 7,381.51
PE Ratio 13.73
Forward PE 9.05
Dividend 503.41 (2.50%)
Ex-Dividend Date Jun 13, 2025
Volume 636
Average Volume 4,986
Open 20,200
Previous Close 20,075
Day's Range 20,100 - 20,600
52-Week Range 16,950 - 37,175
Beta 0.40
RSI 64.58
Earnings Date Jul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.